• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Bausch & Lomb opens new pharma headquarters


Bausch & Lomb has opened a new 300,000-square-foot global pharmaceutical headquarters building in Madison, NJ. The company maintains its worldwide headquarters in Rochester, NY, and has research and development functions in locations around the world.

Key Points

Bausch & Lomb said that its decision to locate the pharmaceutical facility in New Jersey stemmed from the fact that the state is the home to world or North American headquarters or significant operations of 15 of the world's top 25 pharmaceutical companies.

"Establishing our global pharmaceutical headquarters in New Jersey opens up opportunities to partner with other pharmaceutical companies and to drive commercialization of new products. Our recently announced co-promotion agreement with Pfizer for prescription ophthalmics in the United States is the first example of how we are successfully implementing this strategy," said Gerald M. Ostrov, chairman and chief executive officer of the company.

Seventy new full-time jobs will be created at the facility, according to the company.

© 2024 MJH Life Sciences

All rights reserved.